Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hypertension

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 88 articles:
HTML format
Text format



Single Articles


    May 2017
  1. DAVIS J
    Putting the Brakes on Hypertensive Remodeling: An ATF3 Mechanism of Myofibroblast Restraint.
    Circulation. 2017;135:2058-2061.
    PubMed     Text format    


  2. SOLIMAN EZ, Ambrosius WT, Cushman WC, Zhang ZM, et al
    Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients with Hypertension: The Systolic Blood Pressure Intervention (SPRINT) Trial.
    Circulation. 2017 May 16. pii: CIRCULATIONAHA.117.028441.
    PubMed     Text format     Abstract available


    April 2017
  3. AUBDOOL AA, Thakore P, Argunhan F, Smillie SJ, et al
    A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy and Heart Failure.
    Circulation. 2017 Apr 26. pii: CIRCULATIONAHA.117.028388.
    PubMed     Text format     Abstract available


  4. PHILLIPS RA
    Hypertension Treatment and Outcomes in the Era of Population Health, Coordinated Care, and Medicare Access and CHIP Reauthorization Act (MACRA).
    Circulation. 2017;135:1629-1631.
    PubMed     Text format    


  5. BOYD HA, Basit S, Behrens I, Leirgul E, et al
    Association Between Fetal Congenital Heart Defects and Maternal Risk of Hypertensive Disorders of Pregnancy in the Same Pregnancy and Across Pregnancies.
    Circulation. 2017 Apr 19. pii: CIRCULATIONAHA.116.024600.
    PubMed     Text format     Abstract available


    March 2017
  6. HWANGBO C, Lee HW, Kang H, Ju H, et al
    Modulation of Endothelial BMPR2 Activity by VEGFR3 in Pulmonary Arterial Hypertension.
    Circulation. 2017 Mar 29. pii: CIRCULATIONAHA.116.025390.
    PubMed     Text format     Abstract available


  7. CAILLON A, Mian MO, Fraulob-Aquino JC, Huo KG, et al
    Gamma Delta T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury.
    Circulation. 2017 Mar 22. pii: CIRCULATIONAHA.116.027058.
    PubMed     Text format     Abstract available


    February 2017
  8. CHEN J, Sysol JR, Singla S, Zhao S, et al
    Nicotinamide Phosphoribosyltransferase Promotes Pulmonary Vascular Remodeling and is a Therapeutic Target in Pulmonary Arterial Hypertension.
    Circulation. 2017 Feb 15. pii: CIRCULATIONAHA.116.024557.
    PubMed     Text format     Abstract available


    January 2017
  9. YANG P, Read C, Kuc RE, Buonincontri G, et al
    Elabela/Toddler is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of its Expression in Pulmonary Arterial Hypertension.
    Circulation. 2017 Jan 30. pii: CIRCULATIONAHA.116.023218.
    PubMed     Text format     Abstract available


  10. WHELTON SP, Blumenthal RS
    Beyond the Headlines: Insights on Potassium Supplementation for the Treatment of Hypertension From the Canadian Hypertension Education Program Guidelines (CHEP).
    Circulation. 2017;135:3-4.
    PubMed     Text format    


  11. LA GERCHE A, Brosnan MJ
    Cardiovascular Effects of Performance-Enhancing Drugs.
    Circulation. 2017;135:89-99.
    PubMed     Text format     Abstract available


    December 2016
  12. INAMI T, Kataoka M, Yanagisawa R, Ishiguro H, et al
    Long-Term Outcomes After Percutaneous Transluminal Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
    Circulation. 2016;134:2030-2032.
    PubMed     Text format    


  13. MARQUES FZ, Nelson EM, Chu PY, Horlock D, et al
    High Fibre Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in DOCA-Salt Hypertensive Mice.
    Circulation. 2016 Dec 7. pii: CIRCULATIONAHA.116.024545.
    PubMed     Text format     Abstract available


  14. WILLIAMS B
    Time to Abandon Clinic Blood Pressure for the Diagnosis of Hypertension?
    Circulation. 2016;134:1808-1811.
    PubMed     Text format    


  15. SCHWARTZ JE, Burg MM, Shimbo D, Broderick JE, et al
    Clinic Blood Pressure Underestimates Ambulatory Blood Pressure in an Untreated Employer-Based US Population: Results From the Masked Hypertension Study.
    Circulation. 2016;134:1794-1807.
    PubMed     Text format     Abstract available


    November 2016
  16. MCEVOY JW, Martin SS, Dardari ZA, Miedema MD, et al
    Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy.
    Circulation. 2016 Nov 23. pii: CIRCULATIONAHA.116.025471.
    PubMed     Text format     Abstract available


  17. RHODES CJ, Ghataorhe P, Wharton J, Rue-Albrecht KC, et al
    Plasma Metabolomics Implicate Modified Transfer RNAs and Altered Bioenergetics in the Outcome of Pulmonary Arterial Hypertension.
    Circulation. 2016 Nov 21. pii: CIRCULATIONAHA.116.024602.
    PubMed     Text format     Abstract available


  18. MAHMOODI BK, Cushman M, Naess IA, Allison MA, et al
    Association of Traditional Cardiovascular Risk Factors with Venous Thromboembolism: An Individual Participant Data Meta-analysis of Prospective Studies.
    Circulation. 2016 Nov 9. pii: CIRCULATIONAHA.116.024507.
    PubMed     Text format     Abstract available


  19. WALSH KB, Woo D, Sekar P, Osborne J, et al
    Untreated Hypertension: A Powerful Risk Factor for Lobar and Nonlobar Intracerebral Hemorrhage in Whites, Blacks, and Hispanics.
    Circulation. 2016;134:1444-1452.
    PubMed     Text format     Abstract available


  20. ST-ONGE MP, Grandner MA, Brown D, Conroy MB, et al
    Sleep Duration and Quality: Impact on Lifestyle Behaviors and Cardiometabolic Health: A Scientific Statement From the American Heart Association.
    Circulation. 2016;134:e367-e386.
    PubMed     Text format     Abstract available


    October 2016
  21. BOZKURT B, Aguilar D, Deswal A, Dunbar SB, et al
    Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Oct 31. pii: CIR.0000000000000450.
    PubMed     Text format    


    September 2016
  22. MONTANIEL KR, Harrison DG
    Is Hypertension a Bone Marrow Disease?
    Circulation. 2016 Sep 27. pii: CIRCULATIONAHA.116.024520.
    PubMed     Text format     Abstract available


  23. WANG L, Zhao XC, Cui W, Ma YQ, et al
    Genetic and Pharmacologic Inhibition of the Chemokine Receptor CXCR2 Prevents Experimental Hypertension and Vascular Dysfunction.
    Circulation. 2016 Sep 27. pii: CIRCULATIONAHA.115.020754.
    PubMed     Text format     Abstract available



  24. Correction to: Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension.
    Circulation. 2016;134:e260.
    PubMed     Text format    


  25. LONN EM, Yusuf S
    Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mmHg Target?: An Antagonist View from HOPE-3.
    Circulation. 2016 Sep 12. pii: CIRCULATIONAHA.116.023264.
    PubMed     Text format     Abstract available


  26. OPARIL S, Lewis CE
    Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to < 120/80 mmHg Target?: A Protagonist View from SPRINT.
    Circulation. 2016 Sep 12. pii: CIRCULATIONAHA.116.023263.
    PubMed     Text format     Abstract available


    August 2016
  27. AZIZI M, Pereira H, Hamdidouche I, Gosse P, et al
    Adherence to Antihypertensive Treatment and the Blood Pressure Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.
    Circulation. 2016 Aug 30. pii: CIRCULATIONAHA.116.022922.
    PubMed     Text format     Abstract available


  28. CALHOUN DA
    Renal Nerve Denervation, Adherence, and Management of Resistant Hypertension.
    Circulation. 2016 Aug 30. pii: CIRCULATIONAHA.116.024385.
    PubMed     Text format     Abstract available


  29. VAN DER BRUGGEN CE, Happe CM, Goumans MJ, Bogaard HJ, et al
    Response by van der Bruggen et al to Letter Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
    Circulation. 2016;134:e117-8.
    PubMed     Text format    


  30. KATAOKA M, Satoh T, Fukuda K
    Letter by Kataoka et al Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
    Circulation. 2016;134:e115-6.
    PubMed     Text format    


  31. LI M, Riddle S, Zhang H, D'Alessandro A, et al
    Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Co-Repressor C-terminal Binding Protein-1.
    Circulation. 2016 Aug 25. pii: CIRCULATIONAHA.116.023171.
    PubMed     Text format     Abstract available


  32. LI H, Zhang X, Wang F, Zhou L, et al
    MiR-21 Lowers Blood Pressure in Spontaneous Hypertensive Rats By Up-Regulating Mitochondrial Translation.
    Circulation. 2016 Aug 19. pii: CIRCULATIONAHA.116.023926.
    PubMed     Text format     Abstract available


  33. LAI YC, Gladwin MT
    Response by Lai and Gladwin to Letter Regarding Article, "SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fractio
    Circulation. 2016;134:e79-80.
    PubMed     Text format    


  34. CARLSTROM M, Lundberg JO
    Letter by Carlstrom and Lundberg Regarding Article, "SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction".
    Circulation. 2016;134:e77-8.
    PubMed     Text format    


  35. MORAN AE
    Still on the Road to Worldwide Hypertension Control.
    Circulation. 2016;134:451-4.
    PubMed     Text format    


  36. MILLS KT, Bundy JD, Kelly TN, Reed JE, et al
    Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries.
    Circulation. 2016;134:441-50.
    PubMed     Text format     Abstract available


  37. O'GARA PT
    Management of Hypertension in Patients with Mild-to-Moderate Aortic Stenosis: Navigating the SEAS.
    Circulation. 2016 Aug 2. pii: CIRCULATIONAHA.116.023688.
    PubMed     Text format     Abstract available


  38. NIELSEN OW, Sajadieh A, Sabbah M, Greve AM, et al
    Assessing Optimal Blood Pressure in Patients with Asymptomatic Aortic Valve Stenosis: The SEAS Study.
    Circulation. 2016 Aug 2. pii: CIRCULATIONAHA.115.021213.
    PubMed     Text format     Abstract available


    July 2016
  39. CHOMISTEK AK, Henschel B, Eliassen AH, Mukamal KJ, et al
    Frequency, Type, and Volume of Leisure-Time Physical Activity and Risk of Coronary Heart Disease in Young Women.
    Circulation. 2016;134:290-9.
    PubMed     Text format     Abstract available


  40. BHATT DL, Gersh BJ
    Ruminations About Renal Denervation.
    Circulation. 2016;134:267-9.
    PubMed     Text format    


    May 2016
  41. PRESTON IR, Roberts KE, Miller DP, Sen GP, et al
    Response to Letter Regarding Article, "Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)".
    Circulation. 2016;133:e662.
    PubMed     Text format    


  42. NIKPOUR M, Prior D, Celermajer D
    Letter by Nikpour et al Regarding Article, "Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)".
    Circulation. 2016;133:e661.
    PubMed     Text format    


  43. FUJIMOTO T, Morofuji Y, Horie N, Izumo T, et al
    One Cause of Secondary Hypertension: Neurogenic Etiology.
    Circulation. 2016;133:1985-6.
    PubMed     Text format    


  44. HSU S, Houston BA, Tampakakis E, Bacher AC, et al
    Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension.
    Circulation. 2016 May 11. pii: CIRCULATIONAHA.116.022082.
    PubMed     Text format     Abstract available


  45. MARON BA
    Independence Day: Separating Right Ventricular Function from Pulmonary Arterial Hypertension in Systemic Sclerosis.
    Circulation. 2016 May 11. pii: CIRCULATIONAHA.116.023237.
    PubMed     Text format     Abstract available


    April 2016
  46. DAI Z, Li M, Wharton J, Zhu MM, et al
    PHD2 Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans through HIF-2alpha.
    Circulation. 2016 Apr 25. pii: CIRCULATIONAHA.116.021494.
    PubMed     Text format     Abstract available


  47. BAUDRAND R, Pojoga L, Vaidya A, Garza A, et al
    Response to Letter Regarding Article, "Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects".
    Circulation. 2016;133:e606.
    PubMed     Text format    


  48. CAMPBELL DJ
    Letter by Campbell Regarding Article, "Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects".
    Circulation. 2016;133:e605.
    PubMed     Text format    


  49. QAMAR A, Bhatt DL
    Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease.
    Circulation. 2016;133:1512-5.
    PubMed     Text format    


  50. HOEPER MM
    Residual Pulmonary Hypertension After Pulmonary Endarterectomy: The Fog is Clearing.
    Circulation. 2016 Apr 6. pii: CIRCULATIONAHA.116.022595.
    PubMed     Text format     Abstract available



  51. ECG Response: April 5, 2016.
    Circulation. 2016;133:1419-20.
    PubMed     Text format    


  52. ARANY Z, Elkayam U
    Peripartum Cardiomyopathy.
    Circulation. 2016;133:1397-409.
    PubMed     Text format     Abstract available


  53. HOPPER RK, Moonen JA, Diebold I, Cao A, et al
    In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and its Target Slug.
    Circulation. 2016 Apr 4. pii: CIRCULATIONAHA.115.020617.
    PubMed     Text format     Abstract available


    March 2016
  54. BRITTAIN EL, Talati M, Fessel JP, Zhu H, et al
    Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension.
    Circulation. 2016 Mar 22. pii: CIRCULATIONAHA.115.019351.
    PubMed     Text format     Abstract available


  55. CHIU P, Irons M, van de Rijn M, Liang DH, et al
    Giant Pulmonary Artery Aneurysm in a Patient With Marfan Syndrome and Pulmonary Hypertension.
    Circulation. 2016;133:1218-21.
    PubMed     Text format    



  56. ECG Response: March 22, 2016.
    Circulation. 2016;133:1217.
    PubMed     Text format    


  57. VAN DER BRUGGEN CE, Happe CM, Dorfmuller P, Trip P, et al
    Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle.
    Circulation. 2016 Mar 16. pii: CIRCULATIONAHA.115.020696.
    PubMed     Text format     Abstract available


  58. HUBERS SA, Brown NJ
    Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.
    Circulation. 2016;133:1115-24.
    PubMed     Text format     Abstract available


  59. KOENE RJ, Prizment AE, Blaes A, Konety SH, et al
    Shared Risk Factors in Cardiovascular Disease and Cancer.
    Circulation. 2016;133:1104-14.
    PubMed     Text format     Abstract available


  60. LUFT FC
    11-beta Hydroxysteroid Dehydrogenase-2 and Salt-Sensitive Hypertension.
    Circulation. 2016 Mar 7. pii: CIRCULATIONAHA.116.022038.
    PubMed     Text format     Abstract available


  61. EVANS LC, Ivy JR, Wyrwoll C, McNairn JA, et al
    Conditional Deletion of Hsd11b2 in the Brain Causes Salt Appetite and Hypertension.
    Circulation. 2016 Mar 7. pii: CIRCULATIONAHA.115.019341.
    PubMed     Text format     Abstract available


  62. HALL JE
    Renal Dysfunction, Rather Than Nonrenal Vascular Dysfunction, Mediates Salt-Induced Hypertension.
    Circulation. 2016;133:894-906.
    PubMed     Text format    


  63. MORRIS RC JR, Schmidlin O, Sebastian A, Tanaka M, et al
    Vasodysfunction That Involves Renal Vasodysfunction, Not Abnormally Increased Renal Retention of Sodium, Accounts for the Initiation of Salt-Induced Hypertension.
    Circulation. 2016;133:881-93.
    PubMed     Text format    


  64. MORRIS RC JR, Schmidlin O, Sebastian A, Tanaka M, et al
    Response to Hall.
    Circulation. 2016;133:907.
    PubMed     Text format    


    February 2016
  65. ANTIGNY F, Hautefort A, Meloche J, Belacel-Ouari M, et al
    Potassium-Channel Subfamily K-Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
    Circulation. 2016 Feb 24. pii: CIRCULATIONAHA.115.020951.
    PubMed     Text format     Abstract available


  66. SCHWALM JD, McKee M, Huffman MD, Yusuf S, et al
    Resource Effective Strategies to Prevent and Treat Cardiovascular Disease.
    Circulation. 2016;133:742-55.
    PubMed     Text format     Abstract available


  67. MARON BA, Hess E, Maddox TM, Opotowsky AR, et al
    Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the VA-CART Program.
    Circulation. 2016 Feb 12. pii: CIRCULATIONAHA.115.020207.
    PubMed     Text format     Abstract available


  68. BOBROW K, Farmer AJ, Springer D, Shanyinde M, et al
    Mobile Phone Text Messages to Support Treatment Adherence in Adults With High Blood Pressure (SMS-Text Adherence Support [StAR]): A Single-Blind, Randomized Trial.
    Circulation. 2016;133:592-600.
    PubMed     Text format     Abstract available


  69. LAUFFENBURGER JC, Choudhry NK
    Text Messaging and Patient Engagement in an Increasingly Mobile World.
    Circulation. 2016;133:555-6.
    PubMed     Text format    


    January 2016
  70. DELCROIX M, Lang I, Pepke-Zaba J, Jansa P, et al
    Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Results From an International Prospective Registry.
    Circulation. 2016 Jan 29. pii: CIRCULATIONAHA.115.016522.
    PubMed     Text format     Abstract available


  71. LAI YC, Tabima DM, Dube JJ, Hughan KS, et al
    SIRT3-AMPK Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF).
    Circulation. 2016 Jan 26. pii: CIRCULATIONAHA.115.018935.
    PubMed     Text format     Abstract available


  72. RIBEIRO AL, Duncan BB, Brant LC, Lotufo PA, et al
    Cardiovascular Health in Brazil: Trends and Perspectives.
    Circulation. 2016;133:422-33.
    PubMed     Text format     Abstract available


  73. ZHONG J, Cayir A, Trevisi L, Sanchez-Guerra M, et al
    Traffic-Related Air Pollution, Blood Pressure, and Adaptive Response of Mitochondrial Abundance.
    Circulation. 2016;133:378-87.
    PubMed     Text format     Abstract available


  74. BASU S, Yudkin JS, Sussman J, Millett C, et al
    Alternative Strategies to Achieve Cardiovascular Mortality Goals in China and India: A Microsimulation of Target-Versus Risk-Based Blood Pressure Treatment.
    Circulation. 2016 Jan 13. pii: CIRCULATIONAHA.115.019985.
    PubMed     Text format     Abstract available


    December 2015
  75. DANIELS SR
    How to Define Hypertension in Children and Adolescents.
    Circulation. 2015 Dec 15. pii: CIRCULATIONAHA.115.020531.
    PubMed     Text format     Abstract available


  76. BLACK HR, Sica D, Ferdinand K, White WB, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology.
    Circulation. 2015;132:e298-302.
    PubMed     Text format    


  77. WAXMAN AB, Farber HW
    Using Clinical Trial End Points to Risk Stratify Patients With Pulmonary Arterial Hypertension.
    Circulation. 2015;132:2152-61.
    PubMed     Text format    


    November 2015
  78. ANDERSSON C, Vasan RS
    Lipophilic Statins and Aldosterone Secretion: A Bridge Too Far?
    Circulation. 2015;132:1783-5.
    PubMed     Text format    


  79. GUAN J, Khambhati J, Jones LW, Morgans A, et al
    Cardiology Patient Page. ABCDE Steps for Heart and Vascular Wellness Following a Prostate Cancer Diagnosis.
    Circulation. 2015;132:e218-20.
    PubMed     Text format    


  80. WATANABE Y, Miyata T, Tanemoto K
    Current Clinical Features of New Patients With Takayasu Arteritis Observed From Cross-Country Research in Japan: Age and Sex Specificity.
    Circulation. 2015;132:1701-9.
    PubMed     Text format     Abstract available


    October 2015
  81. KIM JB, Kim K, Lindsay ME, MacGillivray T, et al
    Risk of rupture or dissection in descending thoracic aortic aneurysm.
    Circulation. 2015;132:1620-9.
    PubMed     Text format     Abstract available


    September 2015
  82. ROTH GA, Nguyen G, Forouzanfar MH, Mokdad AH, et al
    Estimates of Global and Regional Premature Cardiovascular Mortality in 2025.
    Circulation. 2015;132:1270-82.
    PubMed     Text format     Abstract available


  83. CIRILLO PM, Cohn BA
    Pregnancy Complications and Cardiovascular Disease Death: Fifty-Year Follow-Up of the Child Health and Development Studies Pregnancy Cohort.
    Circulation. 2015 Sep 21. pii: CIRCULATIONAHA.113.003901.
    PubMed     Text format     Abstract available


  84. SHAH AM, Claggett B, Folsom AR, Lutsey PL, et al
    Ideal Cardiovascular Health During Adult Life and Cardiovascular Structure and Function Among the Elderly.
    Circulation. 2015 Sep 8. pii: CIRCULATIONAHA.115.017882.
    PubMed     Text format     Abstract available


  85. ASHRAFIAN H, Pal N, Sivaswamy N, Mahmod M, et al
    The Effect of Selective Heart Rate Slowing in Heart Failure with Preserved Ejection Fraction.
    Circulation. 2015 Sep 2. pii: CIRCULATIONAHA.115.017119.
    PubMed     Text format     Abstract available


    August 2015
  86. ABRAHAM TM, Pedley A, Massaro JM, Hoffman U, et al
    Association Between Visceral and Subcutaneous Adipose Depots and Incident Cardiovascular Disease Risk Factors.
    Circulation. 2015 Aug 20. pii: CIRCULATIONAHA.114.015000.
    PubMed     Text format     Abstract available


  87. GOLDSTEIN BI, Carnethon MR, Matthews KA, McIntyre RS, et al
    Major Depressive Disorder and Bipolar Disorder Predispose Youth to Accelerated Atherosclerosis and Early Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2015 Aug 10. pii: CIR.0000000000000229.
    PubMed     Text format     Abstract available


  88. HAVRANEK EP, Mujahid MS, Barr DA, Blair IV, et al
    Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2015 Aug 3. pii: CIR.0000000000000228.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: